Tibet Aim Pharm Inc banner

Tibet Aim Pharm Inc
SZSE:002826

Watchlist Manager
Tibet Aim Pharm Inc Logo
Tibet Aim Pharm Inc
SZSE:002826
Watchlist
Price: 21.15 CNY 0.09% Market Closed
Market Cap: ¥4B

Income Statement

Earnings Waterfall
Tibet Aim Pharm Inc

Income Statement
Tibet Aim Pharm Inc

Rotate your device to view
Income Statement
Currency: CNY
Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
3
0
0
0
1
0
1
1
1
2
2
2
3
3
0
2
2
2
2
0
1
0
0
0
1
1
1
2
1
1
0
0
0
1
0
0
Revenue
452
N/A
476
+5%
441
-7%
405
-8%
380
-6%
393
+3%
408
+4%
451
+11%
489
+8%
504
+3%
502
0%
500
0%
553
+11%
543
-2%
573
+5%
609
+6%
603
-1%
665
+10%
693
+4%
717
+4%
725
+1%
754
+4%
772
+2%
799
+3%
857
+7%
842
-2%
847
+1%
803
-5%
667
-17%
656
-2%
643
-2%
642
0%
652
+2%
640
-2%
611
-4%
628
+3%
Gross Profit
Cost of Revenue
(133)
(142)
(130)
(116)
(110)
(122)
(133)
(171)
(333)
(385)
(428)
(437)
(371)
(374)
(383)
(409)
(386)
(426)
(461)
(480)
(465)
(482)
(470)
(475)
(481)
(483)
(483)
(437)
(326)
(306)
(248)
(230)
(206)
(183)
(158)
(136)
Gross Profit
319
N/A
334
+5%
312
-7%
289
-7%
271
-6%
270
0%
275
+2%
280
+2%
156
-44%
119
-24%
74
-38%
63
-15%
182
+190%
169
-7%
190
+12%
201
+6%
217
+8%
238
+10%
232
-3%
238
+3%
261
+10%
272
+4%
302
+11%
324
+7%
376
+16%
359
-5%
365
+2%
366
+0%
341
-7%
350
+3%
394
+13%
411
+4%
446
+8%
457
+2%
454
-1%
492
+8%
Operating Income
Operating Expenses
(269)
(280)
(262)
(236)
(209)
(209)
(221)
(244)
(132)
(95)
(52)
(30)
(134)
(125)
(145)
(155)
(173)
(191)
(186)
(190)
(214)
(221)
(254)
(273)
(323)
(306)
(310)
(312)
(302)
(309)
(347)
(371)
(390)
(411)
(392)
(397)
Selling, General & Administrative
(262)
(275)
(260)
(233)
(221)
(221)
(230)
(245)
(136)
(107)
(64)
(50)
(149)
(147)
(167)
(176)
(181)
(199)
(198)
(203)
(214)
(237)
(265)
(285)
(323)
(316)
(316)
(323)
(292)
(317)
(353)
(366)
(396)
(405)
(398)
(419)
Research & Development
(2)
0
0
0
(4)
0
0
0
(16)
(14)
(15)
(16)
(4)
(5)
(5)
(5)
(6)
(11)
(11)
(11)
(10)
(7)
(9)
(8)
(13)
(13)
(17)
(22)
(13)
(13)
(15)
(14)
(15)
(16)
(10)
(13)
Depreciation & Amortization
(3)
0
0
0
(3)
0
0
0
(5)
0
0
0
(6)
0
0
0
(7)
0
0
0
(13)
0
0
0
(11)
0
0
0
(10)
0
0
0
(8)
0
0
0
Other Operating Expenses
(2)
(5)
(2)
(1)
20
13
9
3
25
26
27
37
26
27
28
27
22
19
24
25
22
23
19
20
23
23
22
33
13
22
22
10
30
11
16
35
Operating Income
51
N/A
54
+7%
49
-8%
53
+8%
62
+16%
62
-1%
55
-11%
37
-33%
24
-36%
24
+3%
22
-9%
33
+51%
49
+47%
44
-9%
45
+2%
46
+3%
43
-6%
47
+8%
46
-2%
48
+4%
47
-2%
51
+9%
48
-5%
51
+7%
53
+3%
53
+0%
54
+3%
54
0%
39
-27%
41
+5%
48
+16%
41
-14%
57
+39%
46
-19%
62
+33%
95
+54%
Pre-Tax Income
Interest Income Expense
(3)
(4)
(2)
0
3
3
2
3
3
3
3
0
(1)
(1)
(1)
(1)
(0)
1
1
2
2
2
3
3
3
3
3
2
4
4
4
4
5
4
4
5
Non-Reccuring Items
(1)
0
0
0
0
1
1
0
1
0
0
0
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
(0)
0
0
0
(20)
0
0
(0)
(0)
(0)
(0)
(0)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
17
14
12
7
3
3
3
4
2
3
2
2
0
5
5
5
4
(1)
(1)
(2)
1
2
2
2
1
1
1
1
0
0
0
(0)
(1)
(1)
(2)
12
Pre-Tax Income
63
N/A
64
+1%
60
-6%
62
+3%
68
+10%
69
+1%
61
-11%
43
-29%
29
-33%
30
+3%
26
-11%
35
+33%
48
+36%
47
-1%
49
+4%
51
+2%
47
-6%
46
-2%
45
-3%
47
+6%
50
+5%
54
+9%
53
-2%
57
+7%
57
0%
56
0%
58
+2%
58
0%
24
-59%
45
+93%
52
+14%
44
-14%
60
+36%
49
-19%
63
+29%
112
+77%
Net Income
Tax Provision
(8)
(8)
(8)
(8)
(7)
(7)
(7)
(6)
(4)
(4)
(5)
(5)
(10)
(11)
(11)
(12)
(6)
(6)
(7)
(6)
(7)
(8)
(8)
(9)
(11)
(11)
(9)
(9)
(8)
(10)
(11)
(10)
(13)
(11)
(18)
(25)
Income from Continuing Operations
55
56
52
53
61
61
55
38
25
26
22
30
37
37
39
39
41
40
38
41
43
47
45
48
46
46
49
49
16
35
41
34
47
38
45
87
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(0)
(0)
(0)
(1)
(2)
(2)
(1)
(1)
Net Income (Common)
55
N/A
56
+1%
52
-7%
53
+2%
61
+13%
61
+1%
55
-10%
38
-31%
25
-33%
26
+2%
22
-16%
30
+38%
37
+24%
37
-1%
39
+5%
39
+1%
41
+6%
40
-2%
38
-6%
41
+8%
42
+3%
46
+8%
44
-3%
47
+5%
44
-5%
44
0%
46
+5%
47
+1%
15
-67%
35
+127%
41
+17%
33
-19%
46
+38%
37
-20%
44
+19%
86
+96%
EPS (Diluted)
0.38
N/A
0.29
-24%
0.27
-7%
0.27
N/A
0.32
+19%
0.31
-3%
0.28
-10%
0.2
-29%
0.13
-35%
0.14
+8%
0.12
-14%
0.16
+33%
0.2
+25%
0.2
N/A
0.21
+5%
0.21
N/A
0.22
+5%
0.23
+5%
0.18
-22%
0.23
+28%
0.22
-4%
0.24
+9%
0.23
-4%
0.24
+4%
0.23
-4%
0.23
N/A
0.24
+4%
0.24
N/A
0.08
-67%
0.18
+125%
0.21
+17%
0.17
-19%
0.25
+47%
0.2
-20%
0.24
+20%
0.47
+96%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett